Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Leo entities : Danaher corporation save search
At 17.42% CAGR, Oligonucleotide Synthesis Market Size is Expected to Reach USD 22584.1 Million in 2028, says Brandessence Market Research
Published: 2022-01-17 (Crawled : 13:30) - prnewswire.com
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
| Email alert
Add to watchlist
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
| Email alert
Add to watchlist
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
| Email alert
Add to watchlist
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IONS | $42.455 1.47% 1.45% 730K
|
Health Technology
| Email alert
Add to watchlist
TWST | $30.81 -2.19% -2.24% 1.4M
|
Health Technology
| Email alert
Add to watchlist
ce mark leo research
Outlook on the Oligonucleotide Synthesis Global Market to 2026 - by Product, Application, End-use and Region
Published: 2021-12-16 (Crawled : 12:30) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 3.32%
H: 0.0%
C: 0.0%
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
application leo
Danaher Announces Passing of Former President & CEO, George M. Sherman
Published: 2021-08-20 (Crawled : 12:15) - prnewswire.com
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: 0.48%
H: 0.59%
C: 0.07%
ceo leo
Oligonucleotide Synthesis Market worth $14.1 billion by 2026 - Exclusive Report by MarketsandMarkets™
Published: 2021-04-09 (Crawled : 15:00) - prnewswire.com
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: 0.09%
H: 0.97%
C: 0.96%
A | $137.49 -1.23% -0.36% 1.6M
|
Health Technology
|
| O: 0.59%
H: 0.35%
C: 0.34%
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: 0.22%
H: 0.0%
C: -1.51%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.0%
H: 1.08%
C: 0.92%
leo
Fortune 500 Leaders Establish the Celonis Business Execution CEO Council
Published: 2021-03-29 (Crawled : 14:15) - prnewswire.com
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -0.64%
H: 1.59%
C: 0.91%
ceo leo
Danaher CEO To Comment On Financial Performance
Published: 2021-01-13 (Crawled : 12:07) - prnewswire.com
DHR | $250.41 -1.07% -0.72% 3.3M
|
Health Technology
|
| O: -0.3%
H: 0.56%
C: -0.05%
ceo leo
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.